Role of vitamin D treatment in glucose metabolism in polycystic ovary syndrome

Fertility and Sterility

Volumn 92, Issue 3, 2009, Pages 1053-1058

  Kotsa, Kalliopi ^a   Yavropoulou, Maria P ^a   Anastasiou, Olympia ^a   Yovos, John G ^a  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

Author keywords

insulin resistance; lipid profile; PCOS insulin sensitivity; Vitamin D3 treatment

Indexed keywords

ALFACALCIDOL; CALCIFEDIOL; CALCIUM ION; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PARATHYROID HORMONE; TRIACYLGLYCEROL;

ADULT; ARTICLE; CALCIUM BLOOD LEVEL; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; FEMALE; GLUCOSE METABOLISM; HUMAN; INSULIN RELEASE; INSULIN RESISTANCE; INTRAVENOUS GLUCOSE TOLERANCE TEST; OBESITY; OBSERVATIONAL STUDY; OVARY POLYCYSTIC DISEASE; PARATHYROID HORMONE BLOOD LEVEL; PRIORITY JOURNAL; TRIACYLGLYCEROL BLOOD LEVEL; VITAMIN BLOOD LEVEL; VITAMIN SUPPLEMENTATION;

ADULT; BLOOD GLUCOSE; BONE DENSITY CONSERVATION AGENTS; CALCIUM; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GLUCOSE; GLUCOSE TOLERANCE TEST; HUMANS; HYDROXYCHOLECALCIFEROLS; INSULIN; INSULIN RESISTANCE; LIPID METABOLISM; OBESITY; PARATHYROID HORMONE; POLYCYSTIC OVARY SYNDROME; VITAMIN D;

EID: 69249212350     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2008.07.1757     Document Type: Article

References (38)

1. Diamanti-Kandarakis E., Kouli C.R., Bergiele A.T., Filandra F.A., Tsianateli T.C., Spina G.G., et al. A survey of the polycystic ovary syndrome in the Greek island of Lesbos: hormonal and metabolic profile. J Clin Endocrinol Metab 84 (1999) 4006-4011
2. Azziz R., Woods K.S., Reyna R., Key T.J., Knochenhauer E.S., and Yildiz B.O. The prevalence and features of the polycystic ovary syndrome in an unselected population. J Clin Endocrinol Metab 89 (2004) 2745-2749
3. Dasgupta S., and Reddy B.M. Present status of understanding on the genetic etiology of polycystic ovary syndrome. J Postgrad Med 54 (2008) 115-125
4. Pasquali R., and Gambineri A. Polycystic ovary syndrome: a multifaceted disease from adolescence to adult age. Ann N Y Acad Sci 1092 (2006) 158-174
5. Grulet H., Hecart A.C., Delemer B., Gross A., Sulmont V., Leutenegger M., et al. Roles of LH and insulin resistance in lean and obese polycystic ovary syndrome. Clin Endocrinol (Oxf) 38 (1993) 621-626
6. Dunaif A., and Finegood D.T. Beta-cell dysfunction independent of obesity and glucose intolerance in the polycystic ovary syndrome. J Clin Endocrinol Metab 81 (1996) 942-947
7. Diamanti-Kandarakis E., and Dunaif A. New perspectives in polycystic ovary syndrome. Trends Endocrinol Metab 7 (1996) 267-271
8. Morin-Papunen L.C., Vauhkonen I., Koivunen R.M., Ruokonen A., and Tapanainen J.S. Insulin sensitivity, insulin secretion, and metabolic and hormonal parameters in healthy women and women with polycystic ovarian syndrome. Hum Reprod 15 (2000) 1266-1274
9. Zeitz U., Weber K., Soegiarto D.W., Wolf E., Balling R., and Erben R.G. Impaired insulin secretory capacity in mice lacking a functional vitamin D receptor. FASEB J 17 (2003) 509-511
10. Ortlepp J.R., Metrikat J., Albrecht M., von Korff A., Hanrath P., and Hoffmann R. The vitamin D receptor gene variant and physical activity predicts fasting glucose levels in healthy young men. Diabet Med 20 (2003) 451-454
11. Bourlon P.M., Billaudel B., and Faure-Dussert A. Influence of vitamin D3 deficiency and 1,25 dihydroxyvitamin D3 on de novo insulin biosynthesis in the islets of the rat endocrine pancreas. J Endocrinol 160 (1999) 87-89
12. Billaudel B.J., Bourlon P.M., Sutter B.C., and Faure-Dussert A.G. Regulatory effect of 1,25-dihydroxyvitamin D3 on insulin release and calcium handling via the phospholipid pathway in islets from vitamin D-deficient rats. J Endocrinol Invest 18 (1995) 673-682
13. Beaulieu C., Kestekian R., Havrankova J., and Gascon-Barré M. Calcium is essential in normalizing intolerance to glucose that accompanies vitamin D depletion in vivo. Diabetes 42 (1993) 35-43
14. Kostiuk l. Changes in calcium homeostasis in the development of diabetes mellitus. Fiziol Zh 44 (1998) 15-31
15. Ikeda K., Matsumoto T., Morita K., Yamato H., Takahashi H., Ezawa I., et al. The role of insulin in the stimulation of renal 1,25-dihydroxyvitamin D synthesis by parathyroid hormone in rats. Endocrinology 121 (1987) 1721-1726
16. Maestro B., Campión J., Dávila N., and Calle C. Stimulation by 1,25-dihydroxyvitamin D3 of insulin receptor expression and insulin responsiveness for glucose transport in U-937 human promonocytic cells. Endocr J 47 (2000) 383-391
17. Thys-Jacobs S., Donovan D., Papadopoulos A., Sarrel P., and Bilezikian J.P. Vitamin D and calcium dysregulation in the polycystic ovarian syndrome. Steroids 64 (1999) 430-435
18. The Rotterdam ESHRE/ASRM-sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod 19 (2004) 41-47
19. Saad M.F., Anderson R.L., Laws A., Watanabe R.M., Kades W.W., Chen Y.D., et al. A comparison between the minimal model and the glucose clamp in the assessment of insulin sensitivity across the spectrum of glucose tolerance. Insulin Resistance Atherosclerosis Study. Diabetes 43 (1994) 1114-1121
20. Krempf M., Got I., Ziegler O., Blanchard P., Ranganathan S., Drouin P., et al. Minimal model for determination of insulin sensitivity: repeatability in control and obese subjects. Diabetes Res Clin Pract 26 (1994) 145-148
21. Bischoff-Ferrari H.A. Optimal serum 25-hydroxyvitamin D levels for multiple health outcomes. Adv Exp Med Biol 624 (2008) 55-71
22. Bischoff-Ferrari H.A., Giovannucci E., Willett W.C., Dietrich T., and Dawson-Hughes B.A. Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes. J Clin Nutr 84 (2006) 18-28
23. Cranney A., Horsley T., O'Donnell S., Weiler H., Puil L., Ooi D., et al. Effectiveness and safety of vitamin D in relation to bone health. Evid Rep Technol Assess (Full Rep) 158 (2007) 1-235
24. Aasheim E.T., Hofsø D., Hjelmesaeth J., Birkeland K.I., and Bøhmer T. Vitamin status in morbidly obese patients: a cross-sectional study. Am J Clin Nutr 87 (2008) 362-369
25. Vilarrasa N., Maravall J., Estepa A., Sánchez R., Masdevall C., Navarro M.A., et al. Low 25-hydroxyvitamin D concentrations in obese women: their clinical significance and relationship with anthropometric and body composition variables. Endocrinol Invest 30 (2007) 653-658
26. Bell N.H., Epstein S., Greene A., Shary J., Oexmann M.J., and Shaw S. Evidence for alteration of the vitamin D-endocrine system in obese subjects. J Clin Invest 76 (1985) 370-373
27. Premoli A.C., Santana L.F., Ferriani R.A., Moura M.D., De Sá M.F., and Reis R.M. Growth hormone secretion and insulin-like growth factor-1 are related to hyperandrogenism in nonobese patients with polycystic ovary syndrome. Fertil Steril 83 (2005) 1852-1855
28. Gómez J.M. The role of insulin-like growth factor I components in the regulation of vitamin D. Curr Pharm Biotechnol 7 (2006) 125-132
29. Wortsman J., Matsuoka L.Y., Chen T.C., Lu Z., and Holick M.F. Decreased bioavailability of vitamin D in obesity. Am J Clin Nutr 72 (2000) 690-693
30. Shi H., Norman A.W., Okamura W.H., Sen A., and Zemel M.B. 1alpha,25-Dihydroxyvitamin D3 modulates human adipocyte metabolism via nongenomic action. FASEB J 15 (2001) 2751-2753
31. Hahn S., Haselhorst U., Tan S., Quadbeck B., Schmidt M., Roesler S., et al. Low serum 25-hydroxyvitamin D concentrations are associated with insulin resistance and obesity in women with polycystic ovary syndrome. Exp Clin Endocrinol Diabetes 114 (2006) 577-583
32. Panidis D., Balaris C., Farmakiotis D., Rousso D., Kourtis A., Balaris V., et al. Serum parathyroid hormone concentrations are increased in women with polycystic ovary syndrome. Clin Chem 51 (2005) 1691-1697
33. Borissova A.M., Tankova T., Kirilov G., Dakovska L., and Kovacheva R. The effect of vitamin D3 on insulin secretion and peripheral insulin sensitivity in type 2 diabetic patients. Int J Clin Pract 57 (2003) 258-261
34. Dahlgren E., Johansson S., Lindstedt G., Knutsson F., Odén A., Janson P.O., et al. Women with polycystic ovary syndrome wedge resected in 1956 to 1965: a long-term follow-up focusing on natural history and circulating hormones. Fertil Steril 57 (1992) 505-513
35. Rutter G.A., Tsuboi T., and Ravier M.A. Ca2+ microdomains and the control of insulin secretion. Cell Calcium 40 (2006) 539-551
36. Holz G.G., Heart E., and Leech C.A. Synchronizing Ca2+ and cAMP oscillations in pancreatic beta-cells: a role for glucose metabolism and GLP-1 receptors? Focus on "regulation of cAMP dynamics by Ca2+ and G protein-coupled receptors in the pancreatic beta-cell: a computational approach". Am J Physiol Cell Physiol 293 (2007) C1924-C1933
37. Panidis D., and Farmakiotis D. Treatment of infertility in the polycystic ovary syndrome. N Engl J Med 356 (2007) 1999-39
38. Panidis D., Farmakiotis D., Rousso D., Kourtis A., Katsikis I., and Krassas G. Obesity, weight loss, and the polycystic ovary syndrome: effect of treatment with diet and orlistat for 24 weeks on insulin resistance and androgen levels. Fertil Steril 89 (2008) 899-906